EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study

Esther Chamorro-de-Vega, Alberto Calvo, María Fernández-Pacheco, Belén Hernández-Muniesa, Rosa Romero-Jiménez, Araceli Casado-Gómez, Esther Ramírez, Grupo de Trabajo Estudio SACVINFA:, Alberto Morell, Nuria Herrero, Bárbara Úbeda, Arantza Ais-Larisgoitia und 4 weitere

Farmacia Hospitalaria · 2024

DOI: 10.1016/j.farma.2024.04.006 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Farmacia Hospitalaria, 2024. Verfasst von Esther Chamorro-de-Vega und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, S…. Hauptthemen laut MEDLINE: Quality of Life. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate health-related quality of life perceived by patients with the most prevalent immune-mediated inflammatory diseases in Spain: inflammatory bowel disease (IBD), psoriasis (Ps), psoriatic arthritis (AP), rheumatoid arthritis (RA), and spondyloarthropathies (SpAs), and to determine the factors that influence patient quality of life. METHODS: The SACVINFA study (SA=satisfaction, CV=quality of life, IN=immune-mediated, FA=pharmacy) consisted of an observational study conducted in 4 hospitals in the Community of Madrid. A cross-sectional analysis was made for adult patients diagnosed with an immune-mediated inflammatory disease who attended the Pharmacy Service. Quality of life was assessed using the EQ-5D-5L questionnaire (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and specific questionnaires: SIBDQ-9, DLQI, PsAQoL, QoL-RA, and ASQoL. RESULTS: A total of 578 patients were analysed (inflammatory bowel disease=25.3%; psoriasis=19.7%; spondyloarthropathies=18.7%; rheumatoid arthritis=18.5%; psoriatic arthritis=17.8%). The mean age (standard deviation) was 49.8 (12.3) years and 50.7% were male. The average score (standard deviation) for the global EQ-5D-5L was 0.771 (0.2) and the mean (standard deviation) visual analogue scale score was 71.5 (20.0). Type of immune-mediated inflammatory diseases was associated with differences in quality of life showing psoriasis and inflammatory bowel disease higher values of EQ5D-5L than psoriatic arthritis, rheumatoid arthritis, and spondyloarthropathies, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeHumansMaleFemaleMiddle AgedCross-Sectional StudiesAdultAgedSpainBiological TherapySurveys and QuestionnairesInflammationInflammatory Bowel DiseasesArthritis, RheumatoidPsoriasis

Stichwörter der Autor:innen

Biological therapiesCalidad de vidaEnfermedades Inflamatorias InmunesImmune-mediated inflammatory diseasesPharmacy serviceQuality of lifeReal-World EvidenceReal-world evidenceServicio de Farmaciaterapias biológicas

Autor:innen und Institutionen

  • Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Pharmacy Department, Hospital Universitario La Princesa, Madrid, Spain.
  • Pharmacy Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
  • Pharmacy Department, Hospital Universitario de Fuenlabrada, Madrid, Spain.
  • Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: rosa.romero@salud.madrid.org.
  • Pharmacoeconomics & Outcomes Research Iberia (PORIB) S.L., Madrid, Spain.

Zitieren

APA

Chamorro-de-Vega, E., Calvo, A., Fernández-Pacheco, M., Hernández-Muniesa, B., Romero-Jiménez, R., Casado-Gómez, A., Ramírez, E., Grupo de Trabajo Estudio SACVINFA:, Morell, A., Herrero, N., Úbeda, B., Ais-Larisgoitia, A., Lobato-Matilla, E., Muñoz, Á., Casado, M. Á., & Escudero-Vilaplana, V. (2024). Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study. Farmacia Hospitalaria. https://doi.org/10.1016/j.farma.2024.04.006

Vancouver

Chamorro-de-Vega E, Calvo A, Fernández-Pacheco M, Hernández-Muniesa B, Romero-Jiménez R, Casado-Gómez A, et al. Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study. Farmacia Hospitalaria. 2024. doi:10.1016/j.farma.2024.04.006

BibTeX
@article{ChamorrodeVega2024,
  author = {Chamorro-de-Vega, Esther and Calvo, Alberto and Fernández-Pacheco, María and Hernández-Muniesa, Belén and Romero-Jiménez, Rosa and Casado-Gómez, Araceli and Ramírez, Esther and Grupo de Trabajo Estudio SACVINFA:, Grupo de Trabajo Estudio SACVINFA: and Morell, Alberto and Herrero, Nuria and Úbeda, Bárbara and Ais-Larisgoitia, Arantza and Lobato-Matilla, Elena and Muñoz, Álvaro and Casado, Miguel Ángel and Escudero-Vilaplana, Vicente},
  title = {Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study},
  journal = {Farmacia Hospitalaria},
  year = {2024},
  doi = {10.1016/j.farma.2024.04.006}
}
Kostenlos starten →